Fujian Academy of Traditional Chinese Medicine Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2012
NCT01834105
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Fujian Academy of Traditional Chinese Medicine | Quanzhou Orthopedic-traumatological Hospital of Fujian Traditional Chinese Medicine University

Active Ingredients

Drugs in Phase 2 Trials (1)

liuwei dihuang (1 trial)

Drugs in Phase 1 Trials (2)

calcitriol (rocaltrol) (1 trial)

xulin jiangu (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Blind Loop Syndrome (Phase 1)

Osteoporosis (Phase 2)

Osteoporosis, Postmenopausal (Phase 2)

Yin Deficiency (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3